The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection

Fabian Klein1, Mladen Mitrovic2, Julien Roux3,4

  • 1Developmental and Molecular Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland f.klein@unibas.ch.

Insights

Researchers found that the transcription factor Duxbl marks T cells that fail to rearrange their beta-chain during development. Duxbl induces apoptosis in these non-selected cells, ensuring proper T cell selection.

Area of Science:

  • Immunology
  • Molecular Biology
  • Developmental Biology

Background:

  • T cell development requires successful antigen-receptor gene rearrangement.
  • The β-selection checkpoint ensures functional T cell receptor (TCR) β-chain rearrangement.
  • The fate of T cells failing β-selection remains poorly understood.

Purpose of the Study:

  • To investigate the molecular mechanisms governing the fate of T cells that fail β-selection.
  • To identify molecular markers and regulators of T cell development at the β-selection checkpoint.

Main Methods:

  • Single-cell transcriptome clustering and expression profiling.
  • Conditional transgenic mouse models for Duxbl manipulation.
  • RNA interference (RNAi) for Duxbl silencing.
  • Analysis of apoptosis pathways (Oas/RNaseL, Bcl2).

Main Results:

  • Low CD27 expression identifies pre-T cells with failed β-chain rearrangement.
  • Transcription factor Duxbl is specifically expressed before β-selection during high recombination activity.
  • Duxbl overexpression causes developmental arrest and apoptosis at the DN3-to-DN4 transition.
  • Duxbl upregulates the Oas/RNaseL apoptosis pathway; Duxbl silencing reduces apoptosis.
  • RNaseL deficiency or Bcl2 overexpression partially rescues Duxbl-induced developmental defects.

Conclusions:

  • Duxbl acts as a critical regulator of β-selection.
  • Duxbl induces apoptosis in T cells with nonfunctional β-chain rearrangements, ensuring developmental progression.
  • The Oas/RNaseL pathway is a key mediator of Duxbl-induced apoptosis during T cell selection.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.8K
Transcription Elongation Factors02:35

Transcription Elongation Factors

4.8K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.0K
Factors Influencing Bioavailability: First-Pass Elimination01:23

Factors Influencing Bioavailability: First-Pass Elimination

When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
8.1K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.2K